Previous Article |
Table of Contents
| Next Article
BIOLOGICAL SCIENCES / PHYSIOLOGY
Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo
Departments of aCell Biology and Physiology and cInternal Medicine, iMolecular Imaging Center, Mallinckrodt Institute of Radiology, and Departments of fPathology and Immunology and jMolecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110-1093; gDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8020; kDivision of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115; and eHoward Hughes Medical Institute, Chevy Chase, MD 20815
Contributed by Lewis C. Cantley, February 8, 2007 (received for review January 2, 2007)
Obesity is a major factor central to the development of insulin resistance and type 2 diabetes. The identification and characterization of genes involved in regulation of adiposity, insulin sensitivity, and glucose uptake are key to the design and development of new drug therapies for this disease. In this study, we show that the polarity kinase Par-1b/MARK2 is required for regulating glucose metabolism in vivo. Mice null for Par-1b were lean, insulin hypersensitive, resistant to high-fat diet-induced weight gain, and hypermetabolic. 18F-FDG microPET and hyperinsulinemiceuglycemic clamp analyses demonstrated increased glucose uptake into white and brown adipose tissue, but not into skeletal muscle of Par-1b null mice relative to wild-type controls. Taken together, these data indicate that Par-1b is a regulator of glucose metabolism and adiposity in the whole animal and may be a valuable drug target for the treatment of both type 2 diabetes and obesity.
glucose | obesity | EMK
Author contributions: J.B.H., M.H., J.L., L.C.C., J.K.K., G.I.S., and H.P.-W. designed research; J.B.H., M.H., L.S.W., J.L., C.S.C., Y.-R.C., H.-J.K., and J.L.P. performed research; J.B.H., D.P.-W., J.K.K., and G.I.S. contributed new reagents/analytic tools; J.B.H., L.S.W., J.L., C.S.C., Y.-R.C., H.-J.K., J.L.P., D.P.-W., L.C.C., J.K.K., G.I.S., and H.P.-W. analyzed data; and J.B.H. wrote the paper.
bPresent address: Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA 02115.
dPresent address: Department of Medicine, Southern Illinois University School of Medicine, Springfield, IL 62901.
hPresent address: Department of Cellular and Molecular Physiology, Pennsylvania State University College of Medicine, Hershey, PA 17033.
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/cgi/content/full/0701179104/DC1.
lTo whom correspondence may be addressed. E-mail: lewis_cantley{at}hms.harvard.edu or hpiwnica{at}cellbiology.wustl.edu
© 2007 by The National Academy of Sciences of the USA
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
A. F. Hezel, S. Gurumurthy, Z. Granot, A. Swisa, G. C. Chu, G. Bailey, Y. Dor, N. Bardeesy, and R. A. DePinho Pancreatic Lkb1 Deletion Leads to Acinar Polarity Defects and Cystic Neoplasms Mol. Cell. Biol., April 1, 2008; 28(7): 2414 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, R. Muniyappa, X. Yan, H. Chen, L. Q. Yue, E.-G. Hong, J. K. Kim, and M. J. Quon Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E261 - E270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Forcet and M. Billaud Dialogue Between LKB1 and AMPK: A Hot Topic at the Cellular Pole Sci. Signal., September 18, 2007; 2007(404): pe51 - pe51. [Abstract] [Full Text] [PDF] |
||||